Hugo Arias-Pulido

Epidermal growth factor receptor as a biomarker for cervical cancer.

N. Joste, C. Muller, C. Verschraegen, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen.

S. Eberhardt, C. Muller, T. Bocklage, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Absence of epidermal growth factor receptor mutations in cervical cancer

N. Joste, C. Muller, C. Verschraegen, 2007, International Journal of Gynecologic Cancer.